SCHEMBL629080

SCHEMBL629080

NS(=O)(=O)CC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL674966 0.73
SCHEMBL830748 0.72 POLB (1.00)
SCHEMBL3076944 0.71
SCHEMBL9635561 0.71
SCHEMBL27547331 0.71
SCHEMBL13255293 0.71
SCHEMBL7962385 0.69 POLB (0.93)
Ethanesulfonic Acid Amide SCHEMBL9491342 0.69 FFAR3 (0.41)
Malonic Acid SCHEMBL28896908 0.69 LDHA (0.64)
Succinic Acid SCHEMBL1857902 0.69 LMNA (0.64)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 147 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1174151-B1 THERAPEUTIC TREATMENT OF EOSINOPHILIA USING CHYMASE INHIBITORS AS THE ACTIVE INGREDIENT DAIICHI ASUBIO PHARMA CO LTD (JP) 2007-01-24 EP claimed
US-6677344-B2 Chymase inhibitor for the treatment of eosinophilia DAIICHI SUNTORY PHARMA CO., LTD. (JP) 2004-01-13 US claimed
US-6500835-B2 FOR PROPHYLAXIS AND THERAPY OF FIBROSIS INVOLVING EXTRACELLULAR MATRIX DYSBOLISM HAVING A CHYMASE INHIBITOR AS AN EFFECTIVE INGREDIENT; SIDE EFFECT REDUCTION SUNTORY LIMITED (JP) 2002-12-31 US claimed
EP-0282079-B1 COATING COMPOSITION WITH IMPROVED RUST-PREVENTING PROPERTIES FOR USE IN PREPARING LUBRICATED STEEL PRODUCTS NIPPON OIL AND FATS COMPANY, LIMITED (JP) 1993-03-03 EP claimed
US-4758665-A Process for preparing high-hiding gamma-modification of unsubstituted linear transquinacridone HOECHST AKTIENGESELLSCHAFT (DE) 1988-07-19 US claimed
CN-116075502-B Antiviral compounds and methods for treating RNA virus (particularly covd-19) infection 生华生物科技股份有限公司 2024-04-12 CN disclosed
EP-3280707-B1 BICYCLIC QUINAZOLINONE DERIVATIVES HOFFMANN LA ROCHE (CH) 2023-12-20 EP disclosed
CN-116854681-A Hormone receptor modulators for the treatment of metabolic conditions and disorders 阿德利克斯股份有限公司 2023-10-10 CN disclosed
US-11696911-B2 Antiviral compounds and method for treating RNA viral infection, particularly COVID-19 SENHWA BIOSCIENCES, INC. (TW) 2023-07-11 US disclosed
CN-110177783-B Hormone receptor modulators for the treatment of metabolic conditions and disorders 阿德利克斯股份有限公司 2023-06-06 CN disclosed
CN-116075502-A Antiviral compounds and methods for treating RNA virus (particularly covd-19) infection 生华生物科技股份有限公司 2023-05-05 CN disclosed
EP-4126846-A1 ANTIVIRAL COMPOUNDS AND METHOD FOR TREATING HEPATOTROPIC VIRAL INFECTION, PARTICULARLY HEPATITIS B AND HEPATITIS D Senhwa Biosciences, Inc. (TW) 2023-02-08 EP disclosed
EP-0282079-A2 Coating composition with improved rust-preventing properties for use in preparing lubricated steel products NIPPON OIL AND FATS COMPANY, LIMITED (JP) 1988-09-14 EP disclosed
US-4517133-A REACTION OF A SULFONYL CHLORIDE WITH AN ISOCYANATE TEROSON GMBH (DE) 1985-05-14 US disclosed
US-4163797-A CARBAMOYL OR SULFAMOYL STABILIZER THE DOW CHEMICAL COMPANY (US) 1979-08-07 US disclosed
US-3960855-A BACTERICIDES SMITHKLINE CORPORATION (US) 1976-06-01 US disclosed
US-3960852-A BACTERICIDES SMITHKLINE BECKMAN CORPORATION 1976-06-01 US disclosed
US-3960853-A BACTERICIDES SMITHKLINE CORPORATION (US) 1976-06-01 US disclosed
US-3948905-A ANTIBACTERIAL SMITHKLINE CORPORATION (US) 1976-04-06 US disclosed
US-3939266-A BACTERICIDE SMITHKLINE CORPORATION (US) 1976-02-17 US disclosed